BAJAJ BROKING

Notification
No new Notification messages
Grand Continent Hotels IPO is Open!
Apply for the Grand Continent Hotels IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
vivimed labs ltd. stock

VIVIMED LABS LTD. Share Price

4.9 0.00 (0.00%)
Jul 31 2023 12:00AM Pharmaceuticals NSE: VIVIMEDLAB

VIVIMED LABS LTD. Share Price Update

As of the latest trading session, VIVIMED LABS LTD. share price is currently at 4.9, which is up by 0.00 from its previous closing. Today, the stock has fluctuated between 4.88 and 5.24. Over the past year, VIVIMED LABS LTD. has achieved a return of -52.88 %. In the last month alone, the return has been -10.42 %. Read More...

VIVIMED LABS LTD. Performance

Day Range

Low4.88 High5.24
4.90

52 Week Range

Low .00 High 5.24
4.90

VIVIMED LABS LTD. Share Price

532660

VIVIMEDLAB

img img img img
No Data Available

Open Price

5.10

Prev. Close

4.90

Volume (Shares)

20639.00

Total traded value

1.04

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

VIVIMED LABS LTD. Fundamentals


(Standalone)

Market Cap (Cr) 0.0
PE Ratio (TTM) 0.0
Book Value / Share 0.0
Beta 0.0
ROE 0.0%
EPS (TTM) 0.0
Dividend Yield 0.0%
Net Profit Qtr (Cr) 0.0

VIVIMED LABS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 34.23
Operating Expense 41.21
Net Profit -6.97
Net Profit Margin (%) -20.36
Earnings Per Share (EPS) -0.84
EBITDA -0.16
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 22.16
Operating Expense 27.18
Net Profit -4.99
Net Profit Margin (%) -22.51
Earnings Per Share (EPS) -0.60
EBITDA -0.76
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 24.64
Operating Expense 39.75
Net Profit -15.11
Net Profit Margin (%) -61.32
Earnings Per Share (EPS) -1.82
EBITDA -11.07
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 36.39
Operating Expense 30.65
Net Profit 5.51
Net Profit Margin (%) 15.14
Earnings Per Share (EPS) 0.66
EBITDA -21.45
Effective Tax Rate (%) 24.31
Particulars DEC 2023 (Values in Cr)
Revenue 37.14
Operating Expense 53.90
Net Profit -16.17
Net Profit Margin (%) -43.53
Earnings Per Share (EPS) -1.95
EBITDA 0.93
Effective Tax Rate (%) 3.28
Particulars MAR 2024 (Values in Cr)
Revenue 136.80
Operating Expense 184.92
Net Profit -44.38
Net Profit Margin (%) -32.44
Earnings Per Share (EPS) -5.35
EBITDA -24.07
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 176.83
Operating Expense 507.19
Net Profit -328.01
Net Profit Margin (%) -185.49
Earnings Per Share (EPS) -39.56
EBITDA -187.94
Effective Tax Rate (%) 0.64
Particulars MAR 2022 (Values in Cr)
Revenue 218.37
Operating Expense 284.56
Net Profit -67.75
Net Profit Margin (%) -31.02
Earnings Per Share (EPS) -8.17
EBITDA -7.95
Effective Tax Rate (%) -4.34
Particulars MAR 2021 (Values in Cr)
Revenue 210.05
Operating Expense 245.54
Net Profit -29.19
Net Profit Margin (%) -13.89
Earnings Per Share (EPS) -3.52
EBITDA 27.87
Effective Tax Rate (%) 0.78
Particulars MAR 2020 (Values in Cr)
Revenue 276.61
Operating Expense 303.88
Net Profit -19.17
Net Profit Margin (%) -6.93
Earnings Per Share (EPS) -2.31
EBITDA 38.83
Effective Tax Rate (%) 7.56
Particulars MAR 2024 (Values in Cr)
Book Value / Share -5.24
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -11.45
Particulars MAR 2023 (Values in Cr)
Book Value / Share 0.17
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.25
EBITDA Margin -99.42
Particulars MAR 2022 (Values in Cr)
Book Value / Share 39.35
ROE % -18.80
ROCE % -2.15
Total Debt to Total Equity 0.95
EBITDA Margin -2.76
Particulars MAR 2021 (Values in Cr)
Book Value / Share 47.47
ROE % -16.62
ROCE % -0.93
Total Debt to Total Equity 1.07
EBITDA Margin 4.80
Particulars MAR 2020 (Values in Cr)
Book Value / Share 56.85
ROE % -20.75
ROCE % -2.55
Total Debt to Total Equity 1.11
EBITDA Margin 1.75
Particulars MAR 2024 (Values in Cr)
Book Value / Share 6.20
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 5.13
EBITDA Margin -12.96
Particulars MAR 2023 (Values in Cr)
Book Value / Share 11.50
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.43
EBITDA Margin -106.13
Particulars MAR 2022 (Values in Cr)
Book Value / Share 50.57
ROE % -14.96
ROCE % -2.60
Total Debt to Total Equity 0.75
EBITDA Margin -3.56
Particulars MAR 2021 (Values in Cr)
Book Value / Share 58.67
ROE % -4.65
ROCE % 1.87
Total Debt to Total Equity 0.63
EBITDA Margin 16.14
Particulars MAR 2020 (Values in Cr)
Book Value / Share 62.22
ROE % -2.34
ROCE % 2.98
Total Debt to Total Equity 0.62
EBITDA Margin 16.68
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.02
Total Assets 950.91
Total Liabilities 950.91
Total Equity -5.46
Share Outstanding 82913915
Price to Book Ratio 0.00
Return on Assets (%) -4.77
Return on Capital (%) -12.23
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.76
Total Assets 995.05
Total Liabilities 995.05
Total Equity 39.42
Share Outstanding 82913915
Price to Book Ratio 0.58
Return on Assets (%) -33.01
Return on Capital (%) -78.6
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 7.18
Total Assets 1266.01
Total Liabilities 1266.01
Total Equity 364.28
Share Outstanding 82913915
Price to Book Ratio 0.29
Return on Assets (%) -5.34
Return on Capital (%) -9.35
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 6.43
Total Assets 1289.33
Total Liabilities 1289.33
Total Equity 431.57
Share Outstanding 82913915
Price to Book Ratio 0.27
Return on Assets (%) -5.57
Return on Capital (%) -9.49
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 50.48
Total Assets 2209.61
Total Liabilities 2209.61
Total Equity 834.59
Share Outstanding 82913915
Price to Book Ratio 0.12
Return on Assets (%) -4.93
Return on Capital (%) -6.33
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.14
Total Assets 681.46
Total Liabilities 681.46
Total Equity 89.40
Share Outstanding 82913915
Price to Book Ratio 0.00
Return on Assets (%) -6.51
Return on Capital (%) -9.55
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.34
Total Assets 795.82
Total Liabilities 795.82
Total Equity 133.31
Share Outstanding 82913915
Price to Book Ratio 0.58
Return on Assets (%) -41.21
Return on Capital (%) -64.32
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 6.77
Total Assets 1071.78
Total Liabilities 1071.78
Total Equity 457.27
Share Outstanding 82913915
Price to Book Ratio 0.29
Return on Assets (%) -6.32
Return on Capital (%) -8.32
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 6.01
Total Assets 1094.83
Total Liabilities 1094.83
Total Equity 524.46
Share Outstanding 82913915
Price to Book Ratio 0.27
Return on Assets (%) -2.12
Return on Capital (%) -2.75
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 11.08
Total Assets 1067.31
Total Liabilities 1067.31
Total Equity 553.89
Share Outstanding 82913915
Price to Book Ratio 0.12
Return on Assets (%) -1.79
Return on Capital (%) -2.37
Particulars MAR 2024 (Values in Cr)
Net Income -45.82
Cash from Operations -24.08
Cash from Investing 28.28
Cash from Financing -6.03
Net change in Cash -1.73
Free Cash Flow -22.04
Particulars MAR 2023 (Values in Cr)
Net Income -330.65
Cash from Operations 35.32
Cash from Investing -4.96
Cash from Financing -33.78
Net change in Cash -3.42
Free Cash Flow 40.29
Particulars MAR 2022 (Values in Cr)
Net Income -64.27
Cash from Operations 27.54
Cash from Investing -16.41
Cash from Financing -10.37
Net change in Cash 0.75
Free Cash Flow 43.95
Particulars MAR 2021 (Values in Cr)
Net Income -75.76
Cash from Operations 542.20
Cash from Investing 404.00
Cash from Financing -1015.33
Net change in Cash -44.05
Free Cash Flow 542.20
Particulars MAR 2020 (Values in Cr)
Net Income -109.47
Cash from Operations 99.49
Cash from Investing -196.01
Cash from Financing 72.43
Net change in Cash -44.01
Free Cash Flow 212.30
Particulars MAR 2024 (Values in Cr)
Net Income -44.38
Cash from Operations -96.52
Cash from Investing 99.82
Cash from Financing -5.50
Net change in Cash -2.20
Free Cash Flow -93.99
Particulars MAR 2023 (Values in Cr)
Net Income -330.12
Cash from Operations 32.86
Cash from Investing -1.59
Cash from Financing -34.69
Net change in Cash -3.42
Free Cash Flow 34.46
Particulars MAR 2022 (Values in Cr)
Net Income -64.37
Cash from Operations 25.30
Cash from Investing -11.33
Cash from Financing -13.20
Net change in Cash 0.76
Free Cash Flow 36.64
Particulars MAR 2021 (Values in Cr)
Net Income -29.42
Cash from Operations 182.01
Cash from Investing -138.19
Cash from Financing -46.40
Net change in Cash -5.07
Free Cash Flow 246.58
Particulars MAR 2020 (Values in Cr)
Net Income -20.74
Cash from Operations 81.05
Cash from Investing 3.32
Cash from Financing -91.41
Net change in Cash -13.07
Free Cash Flow 81.05
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.73 19.75 2.00 281.47 34.11 / 77.70
BLISS GVS PHARMA LTD 120.85 15.84 1.26 1273.40 92.25 / 184.95
CIPLA LTD 1513.05 24.49 4.30 122196.18 1317.60 / 1702.00
FERMENTA BIOTECH LIMITED 251.25 20.82 2.54 739.45 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.73 22.13 6.24 281.47 34.11 / 77.70
AMRUTAJAN HEALTH LTD 630.50 36.96 6.12 1822.82 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8391.50 125.15 30.88 20978.75 4050.15 / 8869.70
BLISS GVS PHARMA LTD 120.85 15.69 1.24 1273.40 92.25 / 184.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 0.00
  • 26 Days 0.00
  • 10 Days 0.00
  • 50 Days 0.00
  • 12 Days 0.00
  • 100 Days 0.00
  • 20 Days 0.00
  • 200 Days 0.00
0.0
PIVOT
First Resistance 0.0
Second Resistance 0.0
Third Resistance 0.0
First Support 0.0
Second Support 0.0
Third Support 0.0
RSI 0.0
MACD 0.0
Commodity Channel Index (CCI) 0.0
ADX 0.0
Williams % R 0.0

Over 1 Month

down

-10.42

Over 3 Months

down

-27.40

Over 6 Months

down

-48.42

Over 1 Year

down

-52.88

Over 3 Years

down

-22.63

Over 5 Years

down

-38.71

VIVIMED LABS LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

VIVIMED LABS LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
77.41
Promoter Holdings
20.94
FII
1.64
DII
0.0
Promoter Shares(Pledge Percentage)
37.06
Name Category Shares Shares%
Bbr Projects Private Limited Shareholding of Promoter and Promoter Group 9495504.0 11.45
Kitara Piin 1102 Public Shareholding 7766387.0 9.37
Varalwar Sandeep Shareholding of Promoter and Promoter Group 1875647.0 2.26
Varalwar Subhash Shareholding of Promoter and Promoter Group 1616200.0 1.95
William F Harvey Public Shareholding 1369840.0 1.65
Sameer Mahendra Sampat Public Shareholding 1359165.0 1.64
Santosh Varalwar Shareholding of Promoter and Promoter Group 1300254.0 1.57
K India Opportunities Fund Limited Pcc - Cell S Public Shareholding 1219300.0 1.47
Ashish Bharatkumar Shah Public Shareholding 1174856.0 1.42
Manohar Rao Varalwar Shareholding of Promoter and Promoter Group 1034225.0 1.25
Sheetal Varalwar Shareholding of Promoter and Promoter Group 568985.0 0.69
Sujatha Varalwar Shareholding of Promoter and Promoter Group 393995.0 0.48
S Raghunandan Shareholding of Promoter and Promoter Group 317500.0 0.38
Madhavi Varalwar Shareholding of Promoter and Promoter Group 200000.0 0.24
Mamatha Gurnukar Shareholding of Promoter and Promoter Group 150000.0 0.18
Vijaykumar Varalwar Shareholding of Promoter and Promoter Group 150000.0 0.18
Neelima Vijaya Varalwar Shareholding of Promoter and Promoter Group 100000.0 0.12
Satish Gooty Agraharam Shareholding of Promoter and Promoter Group 55635.0 0.07
Chandrashekharrao Sudigali Shareholding of Promoter and Promoter Group 50095.0 0.06
Varalwar Padma Shareholding of Promoter and Promoter Group 33250.0 0.04
Vithabai Varalwar Shareholding of Promoter and Promoter Group 23345.0 0.03

VIVIMED LABS LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2018-09-19 0.4 Final 2018-09-22 Equity shares 2017-09-21 0.4 Final 2017-09-23 Equity shares 2014-09-24 3.0 Final 2014-09-26 Equity shares 2013-09-24 3.0 Final 2013-09-26 Equity shares 2012-09-21 3.0 Final 2012-09-25 Equity shares 2011-09-26 2.0 Final 2011-09-28 Equity shares 2010-09-09 1.5 Final 2010-09-14 Equity shares 2009-09-24 1.5 Final 2009-09-28 Equity shares 2008-09-22 1.0 Final 2008-09-24 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2016-04-06 10.0 2.0 2016-04-08

Learn More About Stocks

About VIVIMED LABS LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by VIVIMED LABS LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Vivimed Labs Ltd?

Answer Field

The share price of Vivimed Labs Ltd for NSE is ₹ 4.95 and for BSE is ₹ 4.90.

What is the Market Cap of Vivimed Labs Ltd?

Answer Field

The market cap of Vivimed Labs Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Vivimed Labs Ltd?

Answer Field

The 52 Week High and Low of Vivimed Labs Ltd for NSE is ₹ 5.25 and ₹ 0.00 and for BSE is ₹ 5.24 and ₹ 0.00.

How to Buy Vivimed Labs Ltd share?

Answer Field

You can trade in Vivimed Labs Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Vivimed Labs Ltd?

Answer Field

The 1 year returns on the stock has been -52.88%.

What is the Current Share Price of Vivimed Labs Ltd?

Answer Field

Vivimed Labs Ltd share price is for NSE ₹ 4.95 & for BSE ₹ 4.90 as on Jul 31 2023 12:00AM.

What is the Market Cap of Vivimed Labs Ltd Share?

Answer Field

The market cap of Vivimed Labs Ltd for NSE ₹ 0.0 & for BSE ₹ 0.0 as on Jul 31 2023 12:00AM.

What is the P/E Ratio of Vivimed Labs Ltd Share?

Answer Field

As on Jul 31 2023 12:00AM the price-to-earnings (PE) ratio for Vivimed Labs Ltd share is 0.0.

What is the PB ratio of Vivimed Labs Ltd Share?

Answer Field

As on Jul 31 2023 12:00AM, the price-to-book (PB) ratio for Vivimed Labs Ltd share is 0.0.

How to Buy Vivimed Labs Ltd Share?

Answer Field

You can trade in Vivimed Labs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Vivimed Labs Ltd Share on Bajaj Broking App?

Answer Field

To buy Vivimed Labs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Vivimed Labs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

9 lakh+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300+ Cr MTF Book

icon-with-text
loader